02/14/2020
2:31 PM | Chione Ltd (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/14/2020
2:07 PM | Karyopharm Therapeutics (Subject)
Palo Alto Investors LP (Filed by)
| Form SC 13G/A
| |
02/14/2020
12:34 PM | Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/14/2020
9:23 AM | Avoro Capital Advisors LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G
| |
02/13/2020
12:43 PM | Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/13/2020
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2020
3:21 PM | Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2020
3:20 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2020
4:07 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
01/13/2020
4:02 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2020
6:12 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2020
4:07 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2020
4:04 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2019
8:15 AM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2019
8:06 AM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2019
3:04 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
4:26 PM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
4:24 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
4:21 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2019
4:18 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2019
6:30 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
4:22 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G
| |
11/12/2019
3:39 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
3:34 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2019
8:03 AM | Karyopharm Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
11/05/2019
3:44 PM | Karyopharm Therapeutics (Issuer)
Lewis Tanya (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/05/2019
3:10 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2019
3:08 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2019
6:23 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2019
6:07 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2019
3:56 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2019
3:54 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
4:06 PM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2019
3:15 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
3:06 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
6:13 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2019
4:00 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G
| |
07/15/2019
3:05 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2019
6:08 PM | Karyopharm Therapeutics (Issuer)
Shah Jatin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2019
12:10 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
6:33 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
7:59 AM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
7:58 AM | Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
7:57 AM | Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
7:55 AM | Garland J. Scott (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
7:54 AM | Dolsten Mikael (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
7:53 AM | BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2019
3:10 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
6:10 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2019
11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT
| |
04/19/2019
3:08 PM | Karyopharm Therapeutics (Filer)
| Form DEFA14A
| |
04/19/2019
3:05 PM | Karyopharm Therapeutics (Filer)
| Form DEF 14A
| |
03/15/2019
6:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
7:28 PM | Chione Ltd (Reporting)
Czernik Marcin (Reporting)
Hadjimichael Andreas (Reporting)
Hadjimichael George (Reporting)
Karyopharm Therapeutics (Issuer)
Smolokowski Wiaczeslaw (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2019
4:03 PM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2019
3:54 PM | Karyopharm Therapeutics (Filer)
| Form POS AM
| |
02/28/2019
3:29 PM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2019
3:17 PM | Karyopharm Therapeutics (Filer)
| Form POSASR
| |
02/28/2019
6:22 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2019
7:12 PM | Chione Ltd (Reporting)
Czernik Marcin (Reporting)
Hadjimichael Andreas (Reporting)
Hadjimichael George (Reporting)
Karyopharm Therapeutics (Issuer)
Smolokowski Wiaczeslaw (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
3:37 PM | Karyopharm Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G
| |
02/25/2019
4:14 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2019
4:09 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2019
4:01 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
3:32 PM | Karyopharm Therapeutics (Issuer)
Peters Cameron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
3:29 PM | Karyopharm Therapeutics (Issuer)
Primiano Christopher Brett (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
3:27 PM | Frenkel Ran (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
3:25 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
3:23 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
3:16 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
3:41 PM | Karyopharm Therapeutics (Subject)
Ridgeback Capital Investments L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
1:54 PM | Karyopharm Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
6:44 AM | Consonance Capital Management LP (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G
| |
02/13/2019
12:42 PM | Chione Ltd (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
02/12/2019
8:45 AM | Karyopharm Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
02/11/2019
3:06 PM | Karyopharm Therapeutics (Subject)
Kauffman Michael (Filed by)
| Form SC 13G/A
| |
01/28/2019
11:51 AM | FRANKLIN RESOURCES INC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G/A
| |
01/24/2019
3:23 PM | Karyopharm Therapeutics (Issuer)
Peters Cameron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2019
3:06 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2019
3:41 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2019
3:37 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
7:26 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2018
3:29 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2018
3:28 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
3:20 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
3:17 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2018
7:03 AM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
7:00 AM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
3:17 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
3:16 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2018
4:12 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2018
6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2018
6:10 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2018
3:09 PM | Karyopharm Therapeutics (Issuer)
Shacham Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2018
3:06 PM | Karyopharm Therapeutics (Issuer)
Kauffman Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2018
3:18 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
